Potential mechanisms responsible for cardioprotective effects of sodium-glucose co-transporter 2 inhibitors
© 2018 The Author(s). Diabetes mellitus currently affects over 350 million patients worldwide and is associated with many deaths from cardiovascular complications. Sodium-glucose co-transporter 2 (SGLT-2) inhibitors are a novel class of antidiabetic drugs with cardiovascular benefits beyond other an...
Saved in:
Main Authors: | Sarayut Lahnwong, Siriporn C. Chattipakorn, Nipon Chattipakorn |
---|---|
Format: | Journal |
Published: |
2018
|
Subjects: | |
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85049855064&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/58871 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
The roles of sodium-glucose cotransporter 2 inhibitors in preventing kidney injury in diabetes
by: Krit Jaikumkao, et al.
Published: (2018) -
The roles of sodium-glucose cotransporter 2 inhibitors in preventing kidney injury in diabetes
by: Krit Jaikumkao, et al.
Published: (2018) -
Acute dapagliflozin administration exerts cardioprotective effects in rats with cardiac ischemia/reperfusion injury
by: Sarayut Lahnwong, et al.
Published: (2020) -
Cardioprotective effect of dipeptidyl peptidase-4 inhibitor during ischemia-reperfusion injury
by: Kroekkiat Chinda, et al.
Published: (2018) -
Cardioprotective effect of dipeptidyl peptidase-4 inhibitor during ischemia-reperfusion injury
by: Kroekkiat Chinda, et al.
Published: (2018)